HST Global, Inc. (HSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
HST Global Market Cap
HST Global has a market cap or net worth of $14.04 thousand as of October 24, 2025. Its market cap has decreased by -96.70% in one year.
Market Cap
14.04K
Enterprise Value
45.23K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 12, 2008, HST Global's market cap has decreased from 11.89M to 14.04K, a decrease of -99.88%. That is a compound annual growth rate of -32.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 14.04K | -99.97% |
| Dec 30, 2024 | 40.61M | 1,173.50% |
| Dec 26, 2023 | 3.19M | 406.25% |
| Dec 30, 2022 | 629.83K | 9.09% |
| Dec 21, 2021 | 577.34K | 88.76% |
| Dec 31, 2020 | 305.86K | -40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |